Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
FFMGF First Mining Finance Corp
PFE Pfizer Inc
BAC Bank of America Corp
$DX US Dollar Currency Index
IL Intralinks Holdings Inc
CRL Charles River Laboratories International Inc
TSLF THL Credit Senior Loan Fund
PSF Cohen & Steers Select Preferred and Income Fund
GUT Gabelli Utility Trust
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company operates in one segment: the development of pharmaceutical products on its own behalf or in collaboration with others. The Company, through its platform technologies, targets a range of diseases and disorders through RNA-targeted mechanisms of action. The Company is also developing therapeutics using its technology for the treatment of drug-resistant bacteria and infectious, rare and other human diseases. The Company's lead Duchenne Muscular Dystrophy (DMD) product candidate, Eteplirsen, is an antisense phosphorodiamidate morpholino oligomer (PMO) therapeutic in Phase III clinical development for the treatment of individuals with DMD having an error in the gene coding for dystrophin that is amenable to skipping exon 51.

Price
Delayed
$25.02
Day's Change
0.36 (1.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.02
Day's Low
24.31
Volume
(Light)

Today's volume of 552,131 shares is on pace to be much lighter than SRPT's 10-day average volume of 2,233,864 shares.

552,131
  • Prev Close
    24.66
  • Today's Open
    24.64
  • Day's Range
    24.31-25.02
  • Avg Vol (10-day)
    2.2M
  • Last (time)
    11:31a ET 07/29/16
  • Last (size)
    100
  • 52-Wk Range
    8.00 - 41.97
    LowHigh
  • (10/05/15 - 04/26/16)
    40.39%
  • 143.2%
  • Market Cap
    1.1B
  • Shares Outstanding
    45.8M
  • -5.01
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.7
  • 72.37
  • (% of float 07/15/16)
    41.47

Latest News

July 20, 2016
7:57 am ET
Zacks
July 19, 2016
4:00 pm ET
BusinessWire
July 14, 2016
11:35 am ET
MarketWatch
July 08, 2016
9:28 am ET
Zacks
June 10, 2016
12:15 pm ET
Zacks
June 09, 2016
9:47 am ET
MarketWatch
7:00 am ET
BusinessWire
June 08, 2016
4:19 pm ET
BusinessWire
1:38 pm ET
Zacks
June 07, 2016
8:51 am ET
MarketWatch
8:30 am ET
MarketWatch
8:29 am ET
MarketWatch
8:23 am ET
Zacks
June 06, 2016
5:40 pm ET
BusinessWire
June 02, 2016
12:11 pm ET
Zacks
10:37 am ET
MarketWatch
9:44 am ET
MarketWatch
8:30 am ET
Zacks
June 01, 2016
1:40 pm ET
Zacks
7:26 am ET
MarketWatch
6:49 am ET
Zacks
May 27, 2016
8:43 am ET
MarketWatch
May 25, 2016
12:35 pm ET
Zacks
9:46 am ET
MarketWatch
9:24 am ET
MarketWatch
7:00 am ET
BusinessWire
May 20, 2016
4:00 pm ET
Globe Newswire
May 10, 2016
5:08 pm ET
BusinessWire
May 06, 2016
12:19 pm ET
BusinessWire
May 05, 2016
7:00 am ET
BusinessWire
May 03, 2016
9:10 am ET
Zacks
May 02, 2016
1:05 pm ET
Zacks
April 28, 2016
9:41 am ET
MarketWatch
9:11 am ET
MarketWatch
8:45 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.